XCath

Private

Surgical robotics company developing the Iris endovascular robotic system, the only such system in development to achieve intracranial navigation for neurointerventional treatment of brain aneurysms

Founders Daniel H. Kim

CEO Daniel H. Kim

Company

Founded

2017

Headquarters

Houston, United States

Financials

Total Funding

$46M

Sectors

Healthtech Hardware

xcath.com

Funding History

2 rounds

Series C Mar 12, 2026

$30M

Crescent Enterprises (Lead) Fred Moll

Series A Nov 1, 2017

$16M

Crescent Enterprises (Lead)

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.